4.2 Article

Mirror neuron system involvement in empathy: A critical look at the evidence

Journal

SOCIAL NEUROSCIENCE
Volume 6, Issue 4, Pages 327-335

Publisher

ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
DOI: 10.1080/17470919.2010.547085

Keywords

Empathy; Mirror neuron system; Imitation; Autism spectrum disorders (ASD)

Funding

  1. Australian National Health and Medical Research Council [566759]
  2. University of Melbourne

Ask authors/readers for more resources

It has been proposed that the human mirror neuron system (MNS) plays an integral role in mediating empathy. In this review, we critically examine evidence from three bodies of research that have been cited as supporting this notion: (1) behavioral studies that have examined the relationship between imitation and empathy, (2) findings from functional neuroimaging studies that report a positive correlation between MNS activation and self-report on an empathy questionnaire, and (3) observations of impaired imitation and empathy in autism spectrum disorders (ASD). In addition, we briefly review lesion studies of the neural correlates of imitation and empathy. Current evidence suggests that the MNS is broadly involved in empathy, but at this stage there has been limited consideration of its various forms, including motor, emotional, and cognitive empathy. There are also various forms of imitation, encompassing emotional and non-emotional, automatic, and voluntary actions. We propose that the relationship between imitation and empathy may vary depending on the specific type of each of these abilities. Furthermore, these abilities may be mediated by partially distinct neural networks, which involve the MNS to a variable degree.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study

Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine C. Nickels, Lieven Lagae, Renzo Guerrini, Sameer M. Zuberi, Rima Nabbout, Kate Riney, Anupam Agarwal, Michael Lock, David Dai, Gail M. Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Shikha Polega, Ronald Davis, Antonio Gil-Nagel

Summary: Long-term use of fenfluramine showed sustained reduction in drop seizure frequency in LGS patients, with significant reduction in the frequency of GTCS and tonic seizures. The drug was generally well tolerated with minimal adverse effects and no significant cardiac side effects observed. Fenfluramine may serve as an important long-term treatment option for patients with LGS.

EPILEPSIA (2023)

Article Biochemistry & Molecular Biology

Genetic aetiologies for childhood speech disorder: novel pathways co-expressed during brain development

Antony Kaspi, Michael S. Hildebrand, Victoria E. Jackson, Ruth Braden, Olivia van Reyk, Tegan Howell, Simone Debono, Mariana Lauretta, Lottie Morison, Matthew J. Coleman, Richard Webster, David Coman, Himanshu Goel, Mathew Wallis, Gabriel Dabscheck, Lilian Downie, Emma K. Baker, Bronwyn Parry-Fielder, Kirrie Ballard, Eva Harrold, Shaun Ziegenfusz, Mark F. Bennett, Erandee Robertson, Longfei Wang, Amber Boys, Simon E. Fisher, David J. Amor, Ingrid E. Scheffer, Melanie Bahlo, Angela T. Morgan

Summary: This study identified new candidate genes associated with childhood apraxia of speech (CAS) through genome sequencing and bioinformatic analysis. The findings highlight the roles of chromatin organization and gene regulation in CAS, and confirm co-expression of CAS-related genes during brain development.

MOLECULAR PSYCHIATRY (2023)

Article Clinical Neurology

Complications of Influenza A or B Virus Infection in Individuals With SCN1A-Positive Dravet Syndrome

Katherine B. Howell, Sophie Butcher, Amy L. Schneider, Sophie Russ-Hall, Pearl R. Muzariri, Rachel Kerr, Isabella Overmars, Michael Hayman, Andrew J. Kornberg, Margie Danchin, Nigel W. Crawford, Ingrid E. Scheffer

Summary: The aim of this study was to determine the frequency and spectrum of complications of influenza infection in individuals with SCN1A-positive Dravet syndrome. The results showed that out of 82 individuals with SCN1A-DS, 24 had confirmed cases of influenza infection, with 75% of them presenting with seizures as the initial symptom. One patient died from influenza pneumonia, and four cases experienced long-term neurological sequelae after the infection.

NEUROLOGY (2023)

Editorial Material Clinical Neurology

ANA Podcasts & Webinars: Genetics of Epilepsy

Rohit R. Das, Adeline L. Goss, Ingrid E. Scheffer

ANNALS OF NEUROLOGY (2023)

Article Behavioral Sciences

Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment

Kim I. Bishop, Peter K. Isquith, Gerard A. Gioia, Kelly G. Knupp, Ingrid E. Scheffer, Rima Nabbout, Nicola Specchio, Joseph Sullivan, Stephane Auvin, J. Helen Cross, Renzo Guerrini, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni

Summary: This study aimed to evaluate the association between fenfluramine (FFA) and improvement in everyday executive function (EF) in preschool-aged children with Dravet syndrome (DS). The results showed that the FFA treatment group demonstrated reliable and clinically meaningful improvement in self-control, flexibility, metacognition, and overall executive function. Among the FFA treatment groups, the 0.7 mg/kg/day dosage group showed the most significant improvement.

EPILEPSY & BEHAVIOR (2023)

Article Biochemistry & Molecular Biology

Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability

David I. Francis, Zornitza Stark, Ingrid E. Scheffer, Tiong Yang Tan, Krithika Murali, Lyndon Gallacher, David J. Amor, Himanshu Goel, Lilian Downie, Chloe A. Stutterd, Emma I. Krzesinski, Anand Vasudevan, Ralph Oertel, Vida Petrovic, Amber Boys, Vivian Wei, Trent Burgess, Karen Dun, Karen L. Oliver, Anne Baxter, Anna Hackett, Samantha Ayres, Sebastian Lunke, Paul Kalitsis, Meaghan Wall

Summary: This study aimed to compare the diagnostic yield of saliva and blood for pathogenic copy number variants (CNVs). The results showed that saliva microarray testing had increased diagnostic utility over blood testing in individuals with syndromic intellectual disability (ID). Mosaic pathogenic CNVs or aneuploidy were detected in saliva but not in blood.

EUROPEAN JOURNAL OF HUMAN GENETICS (2023)

Article Genetics & Heredity

Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare

Zornitza Stark, Tiffany Boughtwood, Matilda Haas, Jeffrey Braithwaite, Clara L. Gaff, Ilias Goranitis, Amanda B. Spurdle, David P. Hansen, Oliver Hofmann, Nigel Laing, Sylvia Metcalfe, Ainsley J. Newson, Hamish S. Scott, Natalie Thorne, Robyn L. Ward, Marcel E. Dinger, Stephanie Best, Janet C. Long, Sean M. Grimmond, John Pearson, Nicola Waddell, Christopher P. Barnett, Matthew Cook, Michael Field, David Fielding, Stephen B. Fox, Jozef Gecz, Adam Jaffe, Richard J. Leventer, Paul J. Lockhart, Sebastian Lunke, Andrew J. Mallett, Julie McGaughran, Linda Mileshkin, Katia Nones, Tony Roscioli, Ingrid E. Scheffer, Christopher Semsarian, Cas Simons, David M. Thomas, David R. Thorburn, Richard Tothill, Deborah White, Sally Dunwoodie, Peter T. Simpson, Peta Phillips, Marie-Jo Brion, Keri Finlay, Michael CJ. Quinn, Tessa Mattiske, Emma Tudini, Kirsten Boggs, Sean Murray, Kathy Wells, John Cannings, Andrew H. Sinclair, John Christodoulou, Kathryn N. North

Summary: Australian Genomics is a national collaborative partnership that aims to integrate genomics into healthcare through a whole-of-system approach. It has evaluated genomic testing outcomes in over 5,200 individuals across rare disease and cancer studies and provided evidence-based changes in policy and practice, resulting in government funding and access to genomic tests. It has also developed national skills, infrastructure, policy, and data resources to support data sharing and improve clinical genomic delivery.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Clinical Neurology

Widespread genomic influences on phenotype in Dravet syndrome, a 'monogenic' condition

Helena Martins Custodio, Lisa M. Clayton, Ravishankara Bellampalli, Susanna Pagni, Katri Silvennoinen, Richard Caswell, John C. Ambrose, Andreas Brunklaus, Renzo Guerrini, Bobby P. C. Koeleman, Johannes R. Lemke, Rikke S. Moler, Ingrid E. Scheffer, Sarah Weckhuysen, Federico Zara, Sameer Zuberi, Karoline Kuchenbaecker, Simona Balestrini, James D. Mills, Sanjay M. Sisodiya

Summary: Dravet syndrome, a rare severe epilepsy caused by SCN1A variants, shows phenotypic heterogeneity that cannot be fully explained by the causal variant or clinical factors. In this study, additional genomic variation and rare variants in epilepsy-related genes were found to contribute to the phenotypic diversity of adults with SCN1A-related Dravet syndrome. The study also revealed differences in polygenic risk scores for intelligence and longevity between Dravet syndrome and epilepsy controls, suggesting that genetic background plays a role in the syndrome's phenotype and mortality risk.

BRAIN (2023)

Article Clinical Neurology

Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies

Alice M. Donnan, Amy L. Schneider, Sophie Russ-Hall, Leonid Churilov, Ingrid E. Scheffer

Summary: This study aims to describe the proportions of patients with commonly encountered genetic developmental and epileptic encephalopathies (DEEs) who developed convulsive status epilepticus (CSE), nonconvulsive status epilepticus (NCSE), and sudden unexplained death in epilepsy (SUDEP). The findings showed that the proportions of these serious presentations vary for different genetic DEEs. These results have important implications for early diagnosis, management, and disease-specific counseling for this high-risk group of conditions.

NEUROLOGY (2023)

Article Genetics & Heredity

Expanding genotype-phenotype correlations in FOXG1 syndrome: results from a patient registry

Elise Brimble, Kathryn G. Reyes, Kopika Kuhathaas, Orrin Devinsky, Maura R. Z. Ruzhnikov, Xilma R. Ortiz-Gonzalez, Ingrid Scheffer, Nadia Bahi-Buisson, Heather Olson

Summary: By evaluating 122 individuals in a patient registry, we have refined the clinical spectrum of FOXG1 syndrome and expanded genotype-phenotype correlations. Core features of the syndrome include delayed or absent developmental milestones, seizures, and movement disorders. Missense variants are associated with milder clinical courses and better developmental outcomes compared to gene deletions and nonsense variants, which are associated with more severe phenotypes and higher seizure burden.

ORPHANET JOURNAL OF RARE DISEASES (2023)

Article Cardiac & Cardiovascular Systems

Is a History of Seizures an Important Risk Factor for Sudden Cardiac Death in Young Athletes?

Elizabeth D. Paratz, Ingrid E. Scheffer, Christopher Semsarian

Summary: This review examines the significance of seizures in young athletes and the complex inter-relationship between seizures, epilepsy, and sudden cardiac death. Recent findings suggest that epilepsy may be associated with sudden unexplained cardiac death, with some patients experiencing a cardiocerebral channelopathy. It is important to consider the possibility of misdiagnosis of cardiac syncope in athletes with a history of seizures, requiring careful cardiac evaluation and risk stratification. Further investigation is needed to fully understand the association between seizures and young sudden cardiac death.

CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE (2023)

Article Clinical Neurology

Familial Mesial Temporal Lobe Epilepsy: Clinical Spectrum and Genetic Evidence for a Polygenic Architecture

Rebekah V. Harris, Karen L. Oliver, Piero Perucca, Pasquale Striano, Angelo Labate, Antonella Riva, Bronwyn E. Grinton, Joshua Reid, Jessica Hutton, Marian Todaro, Terence J. O'Brien, Patrick Kwan, Lynette G. Sadleir, Saul A. Mullen, Emanuela Dazzo, Douglas E. Crompton, Ingrid E. Scheffer, Melanie Bahlo, Carlo Nobile, Antonio Gambardella, Samuel F. Berkovic

Summary: This study analyzed 134 families with familial mesial temporal lobe epilepsy (FMTLE) and found that FMTLE is a generally mild drug-responsive syndrome with the main symptom being déjà vu. Unlike monogenic focal epilepsy syndromes, molecular data supports a polygenic basis for FMTLE. The polygenic risk score (PRS) data suggests that sub-genome-wide significant focal epilepsy genome-wide association study single nucleotide polymorphisms are important risk variants for FMTLE.

ANNALS OF NEUROLOGY (2023)

Article Clinical Neurology

Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies

Sterre Van der Veen, Gabrielle T. W. Tse, Alessandro Ferretti, Giacomo Garone, Bart Post, Nicola Specchio, Victor S. C. Fung, Marina Trivisano, Ingrid E. Scheffer

Summary: In patients with genetic DEEs, a variety of MDs are present, with stereotypies and dystonia being the most common. Different biological mechanisms may lead to different types of MDs.

NEUROLOGY (2023)

Editorial Material Clinical Neurology

Are Germline Mosaic TSC1/2 Variants Present in Controls? Implications for Diagnosis

Zimeng Ye, Sufang Lin, Xia Zhao, Mathew Wallis, Xinyi Gao, Li Sun, Jiarui Wu, Jing Duan, Yi Yao, Lin Li, Li Chen, Dezhi Cao, Zhanqi Hu, Victor W. Zhang, Samuel F. Berkovic, Ingrid E. Scheffer, Jianxiang Liao, Michael S. Hildebrand

PEDIATRIC NEUROLOGY (2024)

Article Cell & Tissue Engineering

Generation of an iPSC line (FINi001-A) from a girl with developmental and epileptic encephalopathy due to a heterozygous gain-of-function p.R1882Q variant in the voltage-gated sodium channel Nav1.2 protein encoded by the SCN2A gene

D. A. Ovchinnikov, S. Jong, C. Cuddy, I. E. Scheffer, S. Maljevic, S. Petrou

Summary: We generated an iPSC cell line from the fibroblasts of a girl with early infantile DEE carrying a gain-of-function mutation in Nav1.2 protein. The established iPSC line exhibited typical characteristics of human pluripotent stem cells and can be used to develop stem cell-based DEE models, contributing to the understanding and potential therapy development for this debilitating condition.

STEM CELL RESEARCH (2023)

No Data Available